Your browser doesn't support javascript.
loading
Safety and efficacy of a new modified intravenous recombinant tissue plasminogen activator (rt-PA) regimen in Chinese patients with acute ischemic stroke: A descriptive retrospective cohort study with subgroup-analysis of different rt-PA dose.
Luo, Yunhe; Li, Jinming; Huang, Ligang; Liu, Xiaochuan; Zhang, Boyu; Lin, Jixian; Jiang, Aihua; Zhao, Jing.
Afiliação
  • Luo Y; Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China.
  • Li J; Department of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
  • Huang L; Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Liu X; Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China; Department of Clinical Medicine, Wannan Medical College, Anhui, China.
  • Zhang B; Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.
  • Lin J; Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China.
  • Jiang A; Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China.
  • Zhao J; Department of Neurology, Minhang Hospital, Fudan University, Shanghai, China. Electronic address: zhao_jing@fudan.edu.cn.
J Clin Neurosci ; 101: 244-251, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35653882

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos / AVC Isquêmico Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos / AVC Isquêmico Idioma: En Ano de publicação: 2022 Tipo de documento: Article